{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T10:34:43Z","timestamp":1782210883804,"version":"3.54.5"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R03NS112078"],"award-info":[{"award-number":["R03NS112078"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jconrel.2020.09.050","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T05:59:17Z","timestamp":1601531957000},"page":"696-709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Incorporation of docosahexaenoic acid (DHA) enhances nanodelivery of antiretroviral across the blood-brain barrier for treatment of HIV reservoir in brain"],"prefix":"10.1016","volume":"328","author":[{"given":"Pengbo","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjie","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Yi","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Lun","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2020.09.050_bb0005","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fcimb.2019.00362","article-title":"Microglial cells: the main HIV-1 reservoir in the brain","volume":"9","author":"Wallet","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0010","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2174\/1570162X14666161006121455","article-title":"Astrocytes as an HIV reservoir: mechanism of HIV infection","volume":"14","author":"Li","year":"2016","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0015","first-page":"528","article-title":"CNS invasion by CD14+\/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection","volume":"7","author":"Fischer-Smith","year":"2001","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0020","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/978-981-13-0484-2_9","article-title":"Cellular determinants of HIV persistence on antiretroviral therapy","volume":"1075","author":"Mikhailova","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0025","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.meegid.2016.08.031","article-title":"HIV-1 drug resistance and resistance testing","volume":"46","author":"Clutter","year":"2016","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0030","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1007\/s00018-014-1702-4","article-title":"The impact of HIV-1 on neurogenesis: implications for HAND","volume":"71","author":"Ferrell","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0035","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s00415-017-8503-2","article-title":"German Association of Neuro-AIDS und Neuro-Infectiology (DGNANI), HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment","volume":"264","author":"Eggers","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0040","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/978-981-13-0484-2_7","article-title":"HIV persistence on antiretroviral therapy and barriers to a cure","volume":"1075","author":"Sung","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0045","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.addr.2011.10.007","article-title":"Nanotechnological advances for the delivery of CNS therapeutics","volume":"64","author":"Wong","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0050","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.addr.2009.11.020","article-title":"Nanotechnology applications for improved delivery of antiretroviral drugs to the brain","volume":"62","author":"Wong","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0055","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/smll.201701921","article-title":"Drug delivery to the brain across the blood-brain barrier using nanomaterials","volume":"13","author":"Tsou","year":"2017","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2020.09.050_bb0060","doi-asserted-by":"crossref","first-page":"101220","DOI":"10.1016\/j.jddst.2019.101220","article-title":"Nanostructured lipidic carriers of lopinavir for effective management of HIV-associated neurocognitive disorder","volume":"53","author":"Garg","year":"2019","journal-title":"J. Drug. Deliv. Sci. Tech."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0065","doi-asserted-by":"crossref","first-page":"10166","DOI":"10.1016\/j.pneurobio.2019.101665","article-title":"Targeting the transferrin receptor for brain drug delivery","volume":"181","author":"Johnsen","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0070","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1211\/jpp.59.7.0004","article-title":"Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain","volume":"59","author":"Gupta","year":"2007","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0075","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2007.06.016","article-title":"Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations","volume":"347","author":"Vyas","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0080","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1007\/s11095-008-9615-2","article-title":"Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, Atazanavir, by a human brain endothelial cell line","volume":"25","author":"Chattopadhyay","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0085","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cbpa.2017.04.019","article-title":"Blood-brain barrier peptide shuttles","volume":"38","author":"S\u00e1nchez-Navarro","year":"2017","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0090","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/17425247.2019.1614911","article-title":"Peptide-mediated drug delivery across the blood-brain barrier for targeting brain tumors","volume":"16","author":"Jafari","year":"2019","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0095","first-page":"61","article-title":"Influence of nanotoxicity on human health and environment: the alternative strategies","volume":"242","author":"Viswanath","year":"2017","journal-title":"Rev. Environ. Contam. Toxicol."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0100","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2217\/nnm.13.204","article-title":"Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine","volume":"9","author":"Xue","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2020.09.050_bb0105","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/nu8010006","article-title":"DHA effects in brain development and function","volume":"8","author":"Lauritzen","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.jconrel.2020.09.050_bb0110","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1017\/S0954422416000184","article-title":"Dietary DHA and health: cognitive function ageing","volume":"29","author":"Cardoso","year":"2016","journal-title":"Nutr. Res. Rev."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0115","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s11095-016-2080-4","article-title":"In vitro modulation of TrkB receptor signaling upon sequential delivery of curcumin-DHA loaded carriers towards promoting neuronal survival","volume":"34","author":"Guerzoni","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0120","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nature13241","article-title":"Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid","volume":"509","author":"Nguyen","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2020.09.050_bb0125","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1089\/aid.2018.0178","article-title":"Simplification of antiretroviral treatment from Darunavir\/ritonavir monotherapy to Darunavir\/Cobicistat monotherapy: Effectiveness and safety in routine clinical practice","volume":"35","author":"Santos","year":"2019","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0130","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ejpb.2004.08.012","article-title":"Targeting of sterically stabilised pH-sensitive liposomes to human T-leukaemia cells","volume":"59","author":"Fonseca","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0135","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ejpb.2014.04.014","article-title":"A new nanostructured carrier design including oil to enhance the pharmaceutical properties of retinoid therapy and its therapeutic effects on chemo-resistant ovarian cancer","volume":"88","author":"Narvekar","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0140","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0022-5347(17)39970-6","article-title":"Elevated transferrin receptor content in human prostate cancer cell lines assessed in vitro and in vivo","volume":"143","author":"Keer","year":"1990","journal-title":"J. Urol."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0145","first-page":"111","article-title":"Effects of HIV-1 tat on secretion of TNF-\u03b1 and IL-1\u03b2 by U87 cells in AIDS patients with or without AIDS dementia complex","volume":"27","author":"Zhao","year":"2014","journal-title":"Biomed. Environ. Sci."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0150","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jneumeth.2018.12.018","article-title":"Perfusion alters free zinc levels in the rodent brain","volume":"315","author":"Lippi","year":"2019","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.jconrel.2020.09.050_bb0155","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1128\/AAC.49.6.2314-2321.2005","article-title":"TMC114, a novel human immunodeficiency virus type 1 protease inhibitor active against protease-inhibitor resistant viruses, including a broad range of clinical isolates","volume":"49","author":"De Meyer","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0160","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40263-016-0405-9","article-title":"Crossing the blood-brain barrier: recent advances in drug delivery to the brain","volume":"31","author":"Patel","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jconrel.2020.09.050_bb0165","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jiac.2016.10.002","article-title":"Current status of HIV\/AIDS in the ART era","volume":"23","author":"Yoshimura","year":"2017","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0170","doi-asserted-by":"crossref","first-page":"5879","DOI":"10.2147\/IJN.S123437","article-title":"Nanomedicine applications in the treatment of breast cancer: current state of the art","volume":"12","author":"Wu","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2020.09.050_bb0175","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/187221013804484827","article-title":"Nanostructured lipid carriers (NLCs) for drug delivery and targeting","volume":"7","author":"Fang","year":"2013","journal-title":"Recent Pat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0180","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2017019047","article-title":"Nanostructured lipid carriers: a new paradigm in topical delivery for dermal and transdermal applications","volume":"34","author":"Sharma","year":"2017","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0185","doi-asserted-by":"crossref","first-page":"12978","DOI":"10.1038\/s41598-019-49362-z","article-title":"Omega-3 fatty acids decrease oxidative stress and inflammation in macrophages from patients with small abdominal aortic aneurysm","volume":"9","author":"Meital","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0190","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3233\/JAD-2010-100462","article-title":"Apical-to-basolateral transport of amyloid-\u03b2 peptides through blood-brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by P-glycoprotein","volume":"22","author":"Candela","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0195","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.biomaterials.2016.01.021","article-title":"Localized delivery of low-density lipoprotein docosahexaenoic acid nanoparticles to the rat brain using focused ultrasound","volume":"83","author":"Mulik","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2020.09.050_bb0200","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.foodchem.2019.01.121","article-title":"Controlled release of microencapsulated docosahexaenoic acid (DHA) by spray-drying processing","volume":"286","author":"Loughrill","year":"2019","journal-title":"Food Chem."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0205","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/adhm.201400214","article-title":"Functionalized nanoscale micelles with brain targeting ability and intercellular microenvironment biosensitivity for anti-intracranial infection applications","volume":"4","author":"Shao","year":"2015","journal-title":"Adv Healthc. Mater."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0210","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1002\/1873-3468.12825","article-title":"Metabolism and functions of docosahexaenoic acid-containing membrane glycerophospholipids","volume":"591","author":"Hishikawa","year":"2017","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0215","first-page":"E128","article-title":"Effect of polyunsaturated fatty acids and some conventional penetration enhancers on transdermal delivery of atenolol","volume":"25","author":"Puglia","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2020.09.050_bb0220","first-page":"70","article-title":"Reversal effect of docosahexaenoic acid on taxol resistance in human ovarian carcinoma A2780\/T cells","volume":"1","author":"Wu","year":"2014","journal-title":"Obstet. Gynecol. Int. J."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0225","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/jphp.12893","article-title":"Pro-inflammatory and anti-inflammatory compounds exert similar effects on P-glycoprotein in blood-brain barrier endothelial cells","volume":"70","author":"Torres-Vergara","year":"2018","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0230","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1248\/bpb.32.1588","article-title":"P-glycoprotein mediates efflux transport of darunavir in human intestinal Caco-2 and ABCB1 gene-transfected renal LLC-PK1 cell lines","volume":"32","author":"Fujimoto","year":"2009","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0235","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.phrs.2015.12.024","article-title":"Mfsd2a-based pharmacological strategies for drug delivery across the blood\u2013brain barrier","volume":"104","author":"Wang","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2020.09.050_bb0240","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature13324","article-title":"Mfsd2a is critical for the formation and function of the blood-brain barrier","volume":"509","author":"Ben-Zvi","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2020.09.050_bb0245","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.neuron.2017.03.043","article-title":"Blood-brain barrier permeability is regulated by lipid transport-dependent suppression of Caveolae-mediated transcytosis","volume":"94","author":"Andreone","year":"2017","journal-title":"Neuron"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920305666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920305666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T03:22:16Z","timestamp":1718421736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365920305666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":49,"alternative-id":["S0168365920305666"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.09.050","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incorporation of docosahexaenoic acid (DHA) enhances nanodelivery of antiretroviral across the blood-brain barrier for treatment of HIV reservoir in brain","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.09.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}